Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v18-FR Version v14-FR
Language French French
Date Updated 2020-07-06 2020-06-08
Drug Identification Number 02425165 02425165
Brand name AURO-GALANTAMINE ER AURO-GALANTAMINE ER
Common or Proper name GALANTAMINE (GALANTAMINE HYDROBROMIDE) GALANTAMINE (GALANTAMINE HYDROBROMIDE)
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients GALANTAMINE GALANTAMINE
Strength(s) 16MG 16MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 30 & 100 30 & 100
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-10-09 2019-10-09
Estimated end date 2020-07-20
Actual end date 2020-07-03
Shortage status Resolved Actual shortage
Company comments
Health Canada comments